CWM
ANGI icon

Chemistry Wealth Management’s Angi Inc ANGI Stock Holding History

Chemistry Wealth Management’s Portfolio ANGI Stock Details ANGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,550
Closed -$192K – 204
2025
Q2 		$192K Buy
+12,550
New +$181K 0.04% 191
2025
Q1 		– Sell
-1,620
Closed -$26.9K – 188
2024
Q4 		$26.9K Sell
1,620
-484
-23% -$10.3K 0.01% 179
2024
Q3 		$54.3K Hold
2,104
– – 0.01% 179
2024
Q2 		$40.4K Hold
2,104
– – 0.01% 166
2024
Q1 		$55.1K Buy
2,104
+219
+12% +$5.58K 0.01% 163
2023
Q4 		$46.9K Sell
1,885
-212
-10% -$4.33K 0.01% 151
2023
Q3 		$41.5K Buy
2,097
+296
+16% +$8.47K 0.01% 144
2023
Q2 		$59.4K Hold
1,801
– – 0.02% 144
2023
Q1 		$40.9K Buy
1,801
+581
+48% +$14.9K 0.01% 141
2022
Q4 		$28.7K Sell
1,220
-860
-41% -$19.2K 0.01% 138
2022
Q3 		$61K Buy
2,080
+97
+5% +$4.27K 0.02% 130
2022
Q2 		$91K Buy
1,983
+321
+19% +$15.8K 0.03% 132
2022
Q1 		$94K Buy
+1,662
New +$121K 0.03% 138

Other funds holding ANGI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Chemistry Wealth Management's ANGI Position: Q3 2025 in Review

Chemistry Wealth Management sold out of Angi Inc (ANGI) in Q3 2025, closing a stake of 12,550 shares — an estimated $192K sold.

Chemistry Wealth Management first reported a position in ANGI in Q1 2022 and held it in 13 quarters. The position peaked at $192K in Q2 2025. 254 funds tracked by Wall St. Rank hold ANGI as of Q3 2025.

  • Chemistry Wealth Management reported no remaining Angi Inc position as of Q3 2025 after selling out during the quarter.
  • Chemistry Wealth Management sold 12,550 Angi Inc shares in Q3 2025, an estimated $192K.
  • Chemistry Wealth Management first reported a position in Angi Inc in Q1 2022 and held it in 13 quarters.
  • Chemistry Wealth Management's Angi Inc position peaked at $192K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Angi Inc as of Q3 2025.

Based on Chemistry Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.